Therapeutic Strategies in Schizophrenia

Description

Updates the reader on the therapeutic options available for the management of schizophrenia, aiding the clinician to translate scientific evidence into improved outcomes. This book also presents a thorough discussion of the new generation of ‘atypical’ antipsychotic drugs – their mode of action and their clinical efficacy in a range of applications. These new agents are compared with existing medications, guiding the reader on their use in combination with other treatments as part of an integrated programme of patient management. Additional special topics covered include metabolic side-effects, early psychosis, cognitive behavioural therapy, comorbid substance abuse and emergencies.

Benefits:
- Translates scientific evidence into improved clinical outcomes - Addresses special topics such as cognitive impairment, early psychosis, compliance and emergencies - Explains mechanisms of typical and atypical antipsychotics and their clinical applications - Synthesizing publication and trial data to enable effective diagnosis and prescribing

Edited by:
AM Mortimer, Department of Psychiatry, University of Hull, Hull, UK; PJ McKenna, Research Psychiatrist, Benito Menni CASM, Barcelona, and CIBERSAM, Spain.

Readership:
Psychiatrists * Psychologists * Hospital pharmacists * Trainees

CONTENTS

1. Metabolic and endocrine effects of antipsychotic agents: scientific theory and clinical practice, V Frighi
2. Dual diagnosis treatment strategies, N Seivewright, R Rele, F Kamal
3. Long-acting antipsychotic injections (LAIs), OS Niaz, PM Haddad
4. Novel antipsychotic drugs: the current climate, AM Mortimer
5. CBT and other psychological strategies in schizophrenia, P McKenna
6. Treatment strategies in early psychosis, RJ Drake, S Lewis
7. Structural and functional brain imaging in schizophrenia, P Salgado-Pineda, E Pomarol-Clotet, PJ McKenna
8. Functional imaging with ligands in schizophrenia: therapeutic inferences, OD Howes, S Kapur
9. When monotherapy is insufficient: the role and effectiveness of additional drugs in schizophrenia, AM Mortimer
10. The current status of clozapine in and beyond treatment resistant schizophrenia, DL Kelly, R Buchanan
11. Neurochemical theories of schizophrenia, PJ McKenna
12. Second generation atypical vs. first generation conventional antipsychotic drug treatment in schizophrenia: another triumph of hope over experience* F Cheng, PB Jones
13. Second-generation antipsychotic drugs: mechanistically distinct or minor variants* JL Waddington, CMP O’Tuathaigh, GJ Remington
14. Disturbed behaviour and its management, S Dye

Abbreviations
General index